Skip to content
OpenCapital
Get started

Aflac AFL Cancer — Future policy benefits

Other product segments

Life insurance
$16.16B-19.9%
Medical and other health
$6.85B-23.0%
Critical care
$6.73B-1.9%
Other
$3.23B-16.7%
Hospital indemnity
$763M-1.2%
Accident
$640M+2.2%
Disability
$633M-8.3%
Dental/vision
$232M-5.3%

Similar metrics at other companies

Horace Mann Educators logo
HMNCancer — Liability for Future Policy Benefit, after Reinsurance
$64.4M-10.7%
Corebridge Financial logo
CRBGCorporate & Other — Future Policy Benefits
$20.1B-2.6%
CNA Financial logo
CNACorporate & Other — Future policy benefits
$0—
Corebridge Financial logo
CRBGLife Insurance — Future Policy Benefits
$13.51B+2.6%
The Hartford Financial Services Group logo
HIGFuture policy benefits
$451M+0.4%
Equitable Holdings logo
EQHFuture policy benefits
$17.44B+0.4%

Other financials

Income statement

See full
Revenue$4.3B+27.9%
Net income$1.0B+3,414%
EPS (diluted)$1.98+3,860%

Balance sheet

See full
Cash & equivalents$5.7B+8.1%
Total debt$8.0B+1.8%
Total equity$30.0B+13.8%
Total assets$116.28B-3.3%

Cash flow

See full
Operating cash flow$968.0M+64.3%

Valuation

See full
Market cap$60.18B+7.8%
Enterprise value$62.52B+6.9%
P/E13×-2.6×
P/S3.3×0.0×

Profitability

See full
Net margin25.6%+4.3pp

Returns & leverage

See full
Return on equity16.5%+2.1pp
Debt / equity0.3×0.0×

Where this comes from

Reported directly by Aflac in its filing.

Tagged under the XBRL concept us-gaap:LiabilityForFuturePolicyBenefits.

The official record: Aflac’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aflac's cancer — future policy benefits.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aflac's cancer — future policy benefits?
Aflac (AFL) reported cancer — future policy benefits of $21.42B in Q1 2026.
How has Aflac's cancer — future policy benefits changed year-over-year?
Aflac's cancer — future policy benefits decreased by 20.5% year-over-year, from $26.94B to $21.42B.
What is the long-term trend for Aflac's cancer — future policy benefits?
Over 2 years (2023 to 2025), Aflac's cancer — future policy benefits has grown at a -12.7% compound annual growth rate (CAGR), from $133.43B to $101.69B.
What does cancer — future policy benefits mean?
The aggregate balance sheet liability representing the present value of future benefits expected to be paid to policyholders in the cancer segment. This is a core measure of the company's long-term financial obligation.